efficacy. PDPGA and synthetic monomer exerted anticancer activity in vitro and in vivo against prostate cancer (PCA) cells via targeting androgen receptor, cell cycle arrest and apoptosis without any toxicity
Gleason score, which is an important histological parameter in determining therapeutic decisions for prostate cancer, has a high level of inter observer variability amongst general and specialist urological pathologists
Prostate cancer is a malignant development of the prostate gland. The prostate is a male regeneration organ that covers the urethra and is located directly under the bladder. The majority ... prostate cancers develop…
type natural product that exhibited potent cytotoxic activity against several cancer cell lines including prostate cancer cell lines. The importance of finding new therapeutic entities against prostate cancer encouraged…
spreads. When cells in the prostate gland begin to grow out of control, prostate cancer develops. The prostate gland is only found in men. It produces some of the fluid
Introduction: Prostate cancer is the second most common cancer and the fifth leading cause of cancer-associated mortality among men worldwide.1 Screening for prostate cancer with serum prostate-specific antigen ... aims…
Prostate cancer (PCa) is the most commonly diagnosed cancer and second leading cause for men in the United States. The majority of prostate cancer (PCa) detected
Cancer begins when cells within the body start to develop out of control. Prostate cancer starts when cells within the prostate organ begin to develop out of control. The prostate ... within the male regenerative…
Introduction: Prostate cancer is the second most com mon form of cancer in men in Brazil. Old age, inadequate diet and weight gain are factors that directly interfere with
Prostate is an associated gland of the male reproductive system. Worldwide, among the men, prostate cancer (PC) is the second most common cancer. PC is the seventh commonest cancers among ... dynamic contrast enhanced…
granted by both the Provincial Health Office and Hospital administration. Results: The prevalence of prostate cancer among urological neoplasms seeing at NTH was found to be 44.3%. It is densely ... male gender starts…
Background: Prostate cancer is a significant healthcare burden in bothdeveloping and under developed countries. Efforts in Saudi Arabia may behindered by the unclarity of awareness of predictors of early prostate…
Current advents of new technology in prostate cancer treatment still carries many problems regarding oncological outcome: Local control remains elusive, with biochemical failure ultimately occurring in half of the…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.